Sabcomeline

Sabcomeline
Clinical data

ATC code	None
Legal status
Legal status	Never marketed
Identifiers
IUPAC name (3R)-N-methoxyquinuclidine-3-carboximidoyl cyanide hydrochloride
CAS Number	159912-58-0
PubChem CID	9577995
IUPHAR/BPS	306
ChemSpider	7852359
UNII	P8P92V596C
ChEMBL	CHEMBL134641
Chemical and physical data
Formula	C₁₀H₁₅N₃O
Molar mass	193.12 g/mol
3D model (Jmol)	Interactive image
SMILES C2CC1CCN2CC1\C(\C#N)=N\OC

Sabcomeline (Memric; SB-202,026) is a selective M₁ receptor partial agonist that was under development for the treatment of Alzheimer's disease. It made it to phase III clinical trials before being discontinued due to poor results.